Lista de obras -

Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome.

artículo científico publicado en 2011

CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke

Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling

artículo científico publicado en 2010

Inferior vena cava parameters predict re-admission in ischaemic heart failure

Intestinal radiation-induced stricture favours small bowel obstruction by phytobezoar: report of a case

scientific article published on 30 June 2009

Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case

artículo científico publicado en 2014

New evidence for nicotinic acid treatment to reduce atherosclerosis

artículo científico publicado en 2010

Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice

artículo científico publicado en 2013

Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways

scientific article published on 10 August 2009

Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function.

artículo científico publicado en 2016

Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability.

artículo científico publicado en 2011

Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcification

artículo científico publicado en 2010

Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome

artículo científico publicado en 2013

Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis.

artículo científico publicado en 2014

The need of identifying circulating biomarkers of coronary dysfunction

artículo científico publicado en 2017

Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury

artículo científico publicado en 2016

Update on the pathophysiological activities of the cardiac molecule cardiotrophin-1 in obesity

artículo científico publicado en 2013

Lista de obras de

Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome.

CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke

Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling

Inferior vena cava parameters predict re-admission in ischaemic heart failure

Intestinal radiation-induced stricture favours small bowel obstruction by phytobezoar: report of a case

Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case

New evidence for nicotinic acid treatment to reduce atherosclerosis

Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice

Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways

Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function.

Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability.

Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcification

Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome

Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis.

The need of identifying circulating biomarkers of coronary dysfunction

Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury

Update on the pathophysiological activities of the cardiac molecule cardiotrophin-1 in obesity